About

Andrea Panunzio is a urologic oncology researcher whose work centers on optimizing surgical outcomes for prostate and bladder cancer patients, with a particular focus on robot-assisted radical prostatectomy (RARP) and radical cystectomy. His major contributions include demonstrating that advanced age independently predicts poorer prognosis and disease progression in high-risk prostate cancer, even after robotic surgery—a finding with over 30 citations. He has also been instrumental in identifying predictive factors for hospital readmission after prostate surgery, showing that extended pelvic lymph node dissection and open surgical approach are independent risk factors. Panunzio’s comparative analysis of robotic versus open radical cystectomy, published in 2022, examined perioperative outcomes and hospital costs in a large-scale national cohort, contributing valuable evidence to the ongoing debate over surgical approach. His work on the ASA physical status system as a predictor of postoperative complications has further refined risk stratification. With multiple publications in high-impact urology journals and a growing citation record exceeding 130 total citations, Panunzio is establishing himself as a thoughtful contributor to evidence-based surgical decision-making in urologic oncology.

Research Focus

Key Achievements

7
H-Index
14
Papers
139
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Advanced age portends poorer prognosis after radical prostatectomy: a single center experience
30 citations · 2022
📈 Most Prolific Year: 2024 (4 Papers)
🤝 Key Collaborators: 73
🏛 Institutions: University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale Vito Fazzi, Azienda Sanitaria Locale Alessandria

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago